ASHEVILLE, N.C. – August 11, 2017 – Asheville Hematology & Oncology is proud to introduce Board Certified Medical Oncologist Louay Hanna, M.D. to their Asheville and Marion cancer treatment teams.
Dr. Hanna earned his medical degree from the University of Damascus, Syria, followed by a residency in internal medicine at NYU Winthrop University in Mineola, New York where he was named “Outstanding Third Year Resident.” He is a member of the American Society of Clinical Oncology and the American College of Physicians.
“We are thrilled to welcome Dr. Hanna to our Asheville and Marion cancer treatment facilities. His expertise in Medical Oncology and Hematology, as well as his dedication to patient care, makes him an invaluable addition to our team,” said Raymond Thertulien, M.D., Ph.D., Hematologist/Medical Oncologist with Asheville Hematology & Oncology.
Dr. Hanna is Board Certified in Internal Medicine and Medical Oncology. His clinical expertise is in Medical Oncology, Internal Medicine and Hematology. Dr. Hanna is specifically interested in immuno-oncology to treat various forms of cancer using the body’s own immune system.
Asheville Hematology & Oncology’s Asheville location is located at 20 Medical Park Drive, and their Marion location is located at 63 South Medical Court.
Asheville Hematology & Oncology is a division of Radiation Therapy Associates of Western North Carolina, P.C., an affiliate of 21st Century Oncology, LLC.
For more information about our services, visit https://asheville.21co.com or call (828) 254-8232.
About 21st Century Oncology:
21st Century Oncology is the largest global, physician led provider of Integrated Cancer Care services. The company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of March 31, 2017, the company operated 179 treatment centers, including 143 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad.